Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Abstract

Obstructive sleep apnea syndrome (OSAS) is a common breathing disorder in sleep in which the airways narrow or collapse during sleep, causing obstructive sleep apnea. The prevalence of OSAS continues to rise worldwide, particularly in middle-aged and elderly individuals. The mechanism of upper airway collapse is incompletely understood but is associated with several factors, including obesity, craniofacial changes, altered muscle function in the upper airway, pharyngeal neuropathy, and fluid shifts to the neck. The main characteristics of OSAS are recurrent pauses in respiration, which lead to intermittent hypoxia (IH) and hypercapnia, accompanied by blood oxygen desaturation and arousal during sleep, which sharply increases the risk of several diseases. This paper first briefly describes the epidemiology, incidence, and pathophysiological mechanisms of OSAS. Next, the alterations in relevant signaling pathways induced by IH are systematically reviewed and discussed. For example, IH can induce gut microbiota (GM) dysbiosis, impair the intestinal barrier, and alter intestinal metabolites. These mechanisms ultimately lead to secondary oxidative stress, systemic inflammation, and sympathetic activation. We then summarize the effects of IH on disease pathogenesis, including cardiocerebrovascular disorders, neurological disorders, metabolic diseases, cancer, reproductive disorders, and COVID-19. Finally, different therapeutic strategies for OSAS caused by different causes are proposed. Multidisciplinary approaches and shared decision-making are necessary for the successful treatment of OSAS in the future, but more randomized controlled trials are needed for further evaluation to define what treatments are best for specific OSAS patients.

Evaluation of bi-directional causal association between obstructive sleep apnoea syndrome and diabetic microangiopathy: a Mendelian randomization study

“…In addition, through pulmonary function testing, we can evaluate the patient's vital capacity, ventilatory function, airflow limitation, and other indicators ( 63 ). These indicators can provide a comprehensive understanding of the respiratory function status of OSAS patients ( 30 , 64 ). In clinical practice, pulmonary function test results can not only guide the selection of treatment strategies.…”

A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options

“…The carcinogenesis and progression of lung cancer involve various factors, including genetic mutations, immunosuppression and evasion, and alterations in the immune microenvironment ( Figure 5 ). The two core pathophysiological mechanisms of OSA, IH and SF, lead to secondary oxidative stress, chronic inflammatory response, and dysfunction of the neuro-endocrine and immune functions, closely associated with cancer ( 102 ). IH can cause changes in cells, factors, and signaling pathways in the TIME, such as remodeling HIF-a1 and TGF-β signaling pathways, activating TAMs, CAFs, and other cells, and promoting PD-1 expression.…”

Recent progresses in gut microbiome mediates obstructive sleep apnea‐induced cardiovascular diseases

“…Individuals with OSA experience narrowing or collapse of the upper airway during sleep, leading to episodes of apnea or hypopnea. Craniofacial abnormalities, such as excessive or elongated soft palate tissue, are a common contributing factor to upper airway stenosis in OSA 49 . Su et al 50 discovered a noteworthy increase in blood vessels in the lamina propria of the soft palate tissue of OSA patients.…”